Finding Ways to Starve the Cancer Seed

Oncologists often describe cancer as a seed that grows in the body's soil. For these seeds to become tumors, the "soil" must be stocked with nutrients such as growth factors to help them proliferate. "Cancer is not a single-cell disease but involves cancer cells and how they collaborate or cooperate with surrounding cells," says Leland Chung, director of molecular urology and therapeutics at Winship Cancer Institute, Emory University School of Medicine. New approaches to starving cancer cells fi

Written byMignon Fogarty
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Blood vessels feed tumors and remove waste products, and they are necessary for tumor growth. Inhibiting this blood vessel growth could prevent tumor growth. "The whole concept is so fundamentally sound," says J. Clifford Murray, University of Nottingham Cancer Research Campaign Department of Clinical Oncology. "The endothelial cell [lining the blood vessels] is immediately attractive because of its accessibility. It's the first cell within a tumor that any reagent is going to reach." The efficacy of this approach, however, is as yet unknown.1 "We are going into a difficult time at the moment, waiting to see if these agents will bear any fruit," says Murray. Oncologists seem most impressed with an antivascular endothelial growth factor (anti-VEGF) monoclonal antibody. "The data at AACR that impressed me the most were the trials of ...[an] anti-VEGF in combination with chemotherapy. Researchers were getting quite significant improvements in survival [rates]," observes Murray.

Much of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies